Sanofi to sell 51% stake in Opella
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R).
Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&R
Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare
Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees
CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French government.
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at $17.4 billion, including debt.
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro
Sanofi Enters Exclusive Talks to Sell 50% Stake in Opella to CD&R
Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered exclusive negotiations to sell a 50% controlling stake in its consumer health division,
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Sanofi enters exclusive talks with CD&R for Opella sale
Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.
Yen on MSN12m
France bristles at painkiller maker's sale to US fund
French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant ...
Sanofi pursues sale of painkiller after political controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after ...
EuropaWire8m
Sanofi and CD&R Join Forces to Propel Opella’s Global Consumer Healthcare Expansion
Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer ...
Daily3h
Sanofi closes deal for consumer health unit Opella: Report
The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the ...
FiercePharma9d
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
Sanofi in Talks With French Government to Address Concerns on Opella Deal
Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a ...